Terumo and DexCom partner on diabetes devices in Japan

Terumo has signed a contract with DexCom to obtain exclusive distribution rights for DexCom's continuous glucose monitors (CGM) in Japan. Sales are expected to begin in 2018, with new products to be launched in stages over several years.

“テルモ、米国デクスコム社と糖尿病領域で提携 持続血糖測定器の日本での独占販売権を取得”nikkei.com

• 1 source
• nikkei.comテルモ、米国デクスコム社と糖尿病領域で提携 - 日本経済新聞Nikkei Inc.May 7, 2018

Summarized from public sources; check the original articles before acting on it.